Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Triple Negative Breast Neoplasms 1Leukemia 1

Interventions

fludarabine 1Transplantation 1Tablets 1Stem Cell Transplantation 1Roflumilast 1Pemetrexed 1Nadolol 1Isoproterenol 1Introns 1FANG vaccine 1Exercise 1Cyclophosphamide 1Counseling 1Cord Blood Stem Cell Transplantation 1Carvedilol 1Bortezomib 1Bisoprolol 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia × Introns × Clear all
NCT02331706 2020-04-21

IFN-DLI for Relapsed Acute Leukemia After Allo-SCT

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed
16 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡